학술논문

Demyelinating polyradiculoneuritis in patients with multiple myeloma: the other side of bortezomib-induced neurotoxicity.
Document Type
Article
Source
Acta Oncologica. Apr2020, Vol. 59 Issue 4, p484-489. 6p. 2 Charts.
Subject
*ELECTROPHYSIOLOGY
*MAGNETIC resonance imaging
*MEDICAL records
*MULTIPLE myeloma
*NEUROTOXICOLOGY
*GUILLAIN-Barre syndrome
*RISK assessment
*SYNDROMES
*SYSTEMATIC reviews
*TREATMENT effectiveness
*RETROSPECTIVE studies
*FUNCTIONAL assessment
*BRAIN-derived neurotrophic factor
*ACQUISITION of data methodology
*BORTEZOMIB
*BLOOD
*DISEASE risk factors
Language
ISSN
0284-186X
Abstract
The article discusses a study which investigated bortezomib-induced neurotoxicity in patients with multiple myeloma. Topics discussed include the development of demyelinating polyradiculoneuritis following treatment with bortezomib, the neurological presentation of bortezomib-induced toxicity including numbness, pain paraesthesia and bilateral motor deficits, and possible pathogenic mechanisms for bortezomib-induced peripheral neuropathy.